A federal advisory committee on autism issues has canceled plans for its first public meeting since new members were ...
Vinay Prasad's unique ability to attract criticism — even when his bosses, including the president, wanted him to keep his ...
WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave ...
Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into another political headache for ...
Meanwhile, Moderna is trying to reset its future around oncology.
Servier said it would buy Day One Biopharmaceuticals, the maker of a drug for childhood brain tumors, in a deal worth roughly $2.5 billion.
China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...
The DOJ's fight against gender-affirming care, the impact of Trump's 'Don't take Tylenol,' and more health news ...
In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.
We recently worked on a National Academies of Sciences, Engineering, and Medicine (NASEM) report that lays out a clear blueprint for a national prevention infrastructure for mental and behavioral ...
Stand Up For Science has become a formal organization and adopted a new strategy that's more confrontational with grassroots ...
For many religious objectors, including Amish, vaccination rejection is a situational interpretation of religious doctrine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results